Violation Tracker Individual Record

Company: 
Janssen Pharmaceuticals, Inc.
Current Parent Company: 
Johnson & Johnson
Penalty: 
$15,100,000
Year: 
2013
Date: 
November 4, 2013
Offense Group: 
healthcare-related offenses
Primary Offense: 
off-label or unapproved promotion of medical products
Secondary Offense: 
kickbacks and bribery
Violation Description: 

Janssen Pharmaceuticals, Inc., a subsidiary of Johnson & Johnson, agreed to pay $15.1 million in settlement of allegations it violated consumer protection laws in promoting Risperdal. This was at the same time as two other settlements, one federal and state, and one multistate, relating to allegations that the company engaged in illegal marketing and making improper payments to providers.

Level of Government: 
state
Action Type: 
agency action
Agency: 
Massachusetts Attorney General
Civil or Criminal Case: 
civil
Facility State: 
Massachusetts
HQ Country of Parent: 
USA
HQ State of Parent: 
New Jersey
Ownership Structure of Parent: 
publicly traded
Major Industry of Parent: 
pharmaceuticals
Specific Industry of Parent: 
pharmaceuticals
Source Notes: 
If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.
Parent company note: 
Parent-subsidiary relationship is current as of the most recent revision listed in the Update Log.